Argenica Therapeutics Limited (ASX:AGN) held its Annual General Meeting of Shareholders at 2:00 PM WST on 19 November 2026 in Perth, Australia, with all four resolutions passed by poll, including the adoption of the Remuneration Report, re-election of a director, approval of an Employee Incentive Plan, and approval of a 10% Placement Capacity.
Key Points
- All resolutions were passed by poll at the Annual General Meeting held on 19 November 2026.
- The Remuneration Report was adopted with 99.46% of votes cast in favour and 0.54% against.
- The re-election of Director Mark Etherton was approved with 99.87% of votes in favour and 0.13% against.
- The Employee Incentive Plan was approved with 99.12% in favour, and the 10% Placement Capacity was approved with 99.40% in favour.
Remuneration Report and Director Re-Election Results
The Remuneration Report was adopted by poll, with 38,839,737 votes cast in favour, representing 99.46% of votes, and 210,339 votes against, representing 0.54%. The resolution to re-elect Director Mark Etherton recorded 41,009,551 votes in favour at 99.87%, with 51,829 votes against at 0.13%. A total of 11,250 votes were recorded as abstaining from the director re-election resolution. Both resolutions were determined by poll in accordance with Listing Rule 3.13.2 and section 251AA of the Corporations Act.
Employee Incentive Plan Approval
The resolution to approve the Employee Incentive Plan was passed by poll, with 36,154,450 votes in favour representing 99.12% of votes cast, and 321,744 votes against representing 0.88%. A total of 106,100 votes were recorded as abstaining from this resolution. Proxy votes received for this resolution included 33,168,848 votes for, 321,744 against, 8,000 votes at the holder's discretion to abstain, and 360,357 votes at discretion. The resolution was passed in accordance with the meeting's voting procedures.
10% Placement Capacity Resolution
The resolution to approve a 10% Placement Capacity was passed by poll, recording 40,789,021 votes in favour at 99.40% and 247,609 votes against at 0.60%. A total of 134,100 votes were recorded as abstaining. Proxy votes received included 37,959,076 votes for, 247,609 against, 36,000 at discretion to abstain, and 204,700 at discretion. The results were disclosed in accordance with Listing Rule 3.13.2 and section 251AA of the Corporations Act, and the company secretary approved the release of the filing.



Please wait processing your request...